Illumina, Inc.

Global Reagents Markets Project Strong Growth Through 2033

Aug 15, 2026

Biotech reagents market projected to hit $148.21B by 2030; life science reagents to reach $114.4B by 2033. Growth driven by precision diagnostics, genomics, and personalized medicine.

GE HealthCare-Mayo MI-BET Collaboration Targets Precision Oncology Growth

Jul 11, 2026

The GE HealthCare-Mayo MI-BET collaboration advances biomarker-guided prostate cancer therapy. The precision oncology market, valued at $122.6B in 2025, is projected to reach $317.2B by 2034, fueled by genomics and targeted treatments.

Omics Markets Projected Strong Growth Across Clinical Trials, Digital PCR Consumables, and Fluidic Samplers

May 08, 2026

Market reports project growth in omics-based clinical trials, Asia digital PCR consumables, and multi-omic fluidic samplers. The clinical trials market is set to reach $47.78B by 2030; fluidic samplers grow to $2.76B by 2036.

Oncology Precision Medicine Market to Reach $366.53 Billion by 2033

Feb 24, 2026

The global oncology precision medicine market is projected to grow from $190.50 billion in 2026 to $366.53 billion by 2033 at a 9.8% CAGR, while the cancer biomarker testing market is expected to reach $96.53 billion by 2033 at a 12.6% CAGR.